ArticleSarcoma2017
Synovial Sarcoma of the Head and Neck: A Single Institution Review.
Article in Sarcoma, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 40 citations in OpenAlex.
- Synovial Sarcoma: Molecular Biology, Pathology, and Therapeutic Strategies.International journal of molecular sciences · 2026Review
- [Synovial sarcoma of the parotid gland: a case report].The Pan African medical journal · 2026Article
- Biphasic Synovial Sarcoma of the Palatine Tonsil: A Case Report and Literature Review.Clinical case reports · 2025Article
- Article
- Tonsillar synovial sarcoma, unusual anatomical location: case report and literature review.Diagnostic pathology · 2024Review
- Lymph node myeloid sarcoma with TP53‑associated myelodysplastic syndrome: A case report.Oncology letters · 2024Article
- Ameloblastoma Transforming into Monophasic Synovial Sarcoma: A Case Report.Journal of maxillofacial and oral surgery · 2024Article
- Synovial sarcoma in the prevertebral space can mimic malignant neurogenic neoplasm: Case report and literature review.Radiology case reports · 2023Article
- Synovial Sarcoma in the Extremity: Diversity of Imaging Features for Diagnosis and Prognosis.Cancers · 2023Review
- Transcervical approach to oropharyngeal synovial sarcoma: a case report.Future science OA · 2022Article
- Synovial sarcoma of the head and neck: A review of reported cases on the clinical characteristics and treatment methods.Frontiers in cell and developmental biology · 2022Review
- Synovial sarcoma of the maxillary sinus and chest wall: An exceptional association of two synchronous rare locations, Case report.Annals of medicine and surgery (2012) · 2021Article
- Nasal spindle cell sarcoma: A case report.International journal of surgery case reports · 2020Article
- Synovial sarcoma of the supraclavicular region causing a hemorrhagic shock.Clinical case reports · 2019Article
- TP53 in bone and soft tissue sarcomas.Pharmacology & therapeutics · 2019Review
- Synovial sarcoma of the maxillary sinus: an extremely rare case with excellent response to chemotherapy.OncoTargets and therapy · 2018Article
- Primary poorly differentiated monophasic synovial sarcoma of ileum mesenteries with pulmonary metastasis: a case report.International journal of clinical and experimental pathology · 2017Article
- Neck synovial sarcoma: case presentation.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prognosis and clinical characteristics of head and neck synovial sarcomas (HNSS) are unclear. Herein, we present an update using a cohort of patients treated at our institution.
methodsWe performed a retrospective chart review of 44 patients diagnosed with primary HNSS between March 1990 and June 2012. Overall survival (OS) and progression-free survival (PFS) curves were estimated and hazard ratios (HRs) were calculated.
resultsThe entire cohort's median PFS was 4.6 years, and 20 of the 44 (45%) patients developed either local or distant recurrence. Tumor size ≥ 5 cm (
conclusionDespite the treatment challenges associated with HNSS, our cohort of patients had a better prognosis than one might expect in this unfavorable anatomical location. Our findings suggest that tumor size and site are predictive of PFS and that wide surgical excision is of vital importance, since traditional cytotoxic chemotherapy has limited efficacy at this site.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.